Scott G. Harroun

Dr. Scott G. Harroun


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
SHScott G. Harroun
Scott G. Harroun
CPCarl Prévost-Tremblay
Carl Prévost-Tremblay
DLDominic Lauzon
Dominic Lauzon
ADArnaud Desrosiers
Arnaud Desrosiers
XWXiaomeng Wang
Xiaomeng Wang
AVAlexis Vallée-Bélisle
Alexis Vallée-Bélisle
DNA switches are ideally suited for numerous nanotechnological applications, and increasing efforts are being directed toward their engineering.

4 March 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
YLYu-Jia Li
Yu-Jia Li
LLLi-Jyuan Luo
Li-Jyuan Luo
SHScott G. Harroun
Scott G. Harroun
SWShih-Chun Wei
Shih-Chun Wei
BUBinesh Unnikrishnan
Binesh Unnikrishnan
Chih-Ching HuangChih-Ching Huang
Chih-Ching Huang
We have developed a rapid and straightforward topical treatment method for dry eye disease (DED) using poly(catechin) capped-gold nanoparticles (Au@Poly-CH NPs) carrying amfenac [AF; a nonsteroidal anti-inflammatory drug (NSAID)] through effective attenuation of ocular surface tissue damage in dry eyes. A dual-targeted strategy based on ocular therapeutics was adopted to simultaneously block the cyclooxygenase enzymes-induced inflammation and reactive oxygen species (ROS)-induced oxidative stress, the primary two causes of DED. The self-assembled core–shell Au@Poly-CH NPs synthesized via a simple reaction between tetrachloroaurate(III) and catechin possess a poly(catechin) shell (∼20 nm) on the surface of each Au NP (∼60 nm). The anti-oxidant and anti-inflammatory properties of AF/Au@Poly-CH NPs were evaluated by DCFH-DA and prostaglandin E2/VEGF assays, respectively. Our results demonstrate that Au@Poly-CH NPs not only act as an anti-oxidant to suppress ROS-mediated processes, but also serve as a drug carrier of AF for a synergistic effect on anti-inflammation. In vivo biocompatibility studies show good tolerability of AF/Au@Poly-CH NPs for potential use in the treatment of ocular surface pathologies. The dual-targeted therapeutic effects of AF/Au@Poly-CH NPs lead to rapid recovery from DED in a rabbit model. Au@Poly-CH NPs loaded with NSAIDs is a promising multifunctional nanocomposite for treating various inflammation- and oxidative stress-related diseases.

29 May 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
HJHong-Jyuan Jian
Hong-Jyuan Jian
AAAnisha Anand
Anisha Anand
Jui-Yang LaiJui-Yang Lai
Jui-Yang Lai
BUBinesh Unnikrishnan
Binesh Unnikrishnan
Huan-Tsung ChangHuan-Tsung Chang
Huan-Tsung Chang
Chih-Ching HuangChih-Ching Huang
Chih-Ching Huang

24 May 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
CHChia-Lun Hsu
Chia-Lun Hsu
YLYu-Jia Li
Yu-Jia Li
HJHong-Jyuan Jian
Hong-Jyuan Jian
SHScott G. Harroun
Scott G. Harroun
SWShih-Chun Wei
Shih-Chun Wei
Huan-Tsung ChangHuan-Tsung Chang
Huan-Tsung Chang
We have developed a simple and green solution for the synthesis of catalytic gold-doped bismuth oxyiodide (Au/BiOI) nanocomposites at room temperature from an aqueous mixture of gold ions, bismuth ions, and iodide ions. Au nanoparticles (NPs) were formed in situ and doped into BiOI nanosheets. The oxygen vacancies generated in BiOI give rise to its oxidase-like activity, and Au doping facilitated the reaction leading to a 4-fold higher oxidase-like activity of the Au/BiOI nanocomposite. The Au/BiOI nanocomposites showed wide spectrum antimicrobial activity not only against non-multidrug-resistant E. coli, K. pneumoniae, S. enteritidis, S. aureus, and B. subtilis bacteria, but also against multidrug-resistant bacteria, methicillin-resistant S. aureus (MRSA). The gold doping reduced the minimal inhibitory concentration value by ∼2000-fold for the Au/BiOI nanocomposite, in comparison with only BiOI nanoparticles. The bactericidal property of the Au/BiOI nanocomposite arose from the combined effect of the disruption of the bacterial membrane through a strong interaction of the nanocomposite with the bacteria and the generation of reactive oxygen species. Also, the Au/BiOI nanocomposite is highly biocompatible, which has been demonstrated in vitro by analysis of cytotoxicity and hemolysis, and in vivo by evaluating ocular tissue responses. Furthermore, intrastromal administration of Au/BiOI nanocomposites can effectively alleviate S. aureus-induced bacterial keratitis in rabbits, suggesting a significant disinfectant benefit in preclinical studies. The Au/BiOI nanocomposites show great potential for the inactivation of bacterial pathogens in an aqueous environment and treatment of bacterial infection-induced diseases.

28 February 2018 in Chemphyschem
Verified
Journal Article
Closed access
PDF file
SHScott G. Harroun
Scott G. Harroun

30 December 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
SHScott G. Harroun
Scott G. Harroun
DLDominic Lauzon
Dominic Lauzon
MEMaximilian C. C. J. C. Ebert
Maximilian C. C. J. C. Ebert
ADArnaud Desrosiers
Arnaud Desrosiers
XWXiaomeng Wang
Xiaomeng Wang
AVAlexis Vallée-Bélisle
Alexis Vallée-Bélisle